Gene · 1973
Papers1,962
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
141 to 160 of 1,962
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Lost in translation: a neglected mTOR target for lymphangioleiomyomatosis. | Eur Respir Rev | 2023 | 37758276 | PubTator, text mining | PubMed |
| Preliminary insights into RNA in CSF of pediatric SMA patients after 6 months of nusinersen. | Biol Direct | 2023 | 37705059 | PubTator, text mining | PubMed |
| Regulation of IGF1R by MicroRNA-15b Contributes to the Anticancer Effects of Calorie Restriction in a Murine C3-TAg Model of Triple-Negative Breast Cancer. | Cancers (Basel) | 2023 | 37686596 | PubTator, text mining | PubMed |
| Advances in Platelet Rich Plasma-Derived Extracellular Vesicles for Regenerative Medicine: A Systematic-Narrative Review. | Int J Mol Sci | 2023 | 37685849 | PubTator, text mining | PubMed |
| Integrative analyses reveal biological function and prognostic role of m7G methylation regulators in high-grade glioma. | Aging (Albany NY) | 2023 | 37679037 | PubTator, text mining | PubMed |
| m7G-related genes predict prognosis and affect the immune microenvironment and drug sensitivity in osteosarcoma. | Front Pharmacol | 2023 | 37654606 | PubTator, text mining | PubMed |
Differential Proteome Profiling Analysis under Pesticide Stress by the Use of a Nano-UHPLC-MS/MS Untargeted Proteomic-Based Approach on a 3D-Developed Neurospheroid Model: Identification of Protein Interactions, Prognostic Biomarkers, and Potential Therapeutic Targets in Human IDH Mutant High-Grade Gliomas. | J Proteome Res | 2023 | 37651309 | PubTator, text mining | PubMed |
| Dynamically regulated two-site interaction of viral RNA to capture host translation initiation factor. | Nat Commun | 2023 | 37640715 | PubTator, text mining | PubMed |
| Translation factor and RNA binding protein mRNA interactomes support broader RNA regulons for posttranscriptional control. | J Biol Chem | 2023 | 37633333 | PubTator, text mining | PubMed |
| Surmounting Cancer Drug Resistance: New Perspective on RNA-Binding Proteins. | Pharmaceuticals (Basel) | 2023 | 37631029 | PubTator, text mining | PubMed |
| Selection and Evaluation of Reference Genes for RT-qPCR Analysis in Amorphophallus Konjac Based on Transcriptome Data. | Genes (Basel) | 2023 | 37628565 | PubTator, text mining | PubMed |
| Convergent somatic evolution commences in utero in a germline ribosomopathy. | Nat Commun | 2023 | 37608017 | PubTator, text mining | PubMed |
| Biological functions and research progress of eIF4E. | Front Oncol | 2023 | 37601696 | PubTator, text mining | PubMed |
| The mechanistic role of cardiac glycosides in DNA damage response and repair signaling. | Cell Mol Life Sci | 2023 | 37584722 | PubTator, text mining | PubMed |
| Establishment of a prognostic model toward lung squamous cell carcinoma based on m7G-related genes in the cancer genome atlas. | Physiol Genomics | 2023 | 37575065 | PubTator, text mining | PubMed |
| RNA binding protein: coordinated expression between the nuclear and mitochondrial genomes in tumors. | J Transl Med | 2023 | 37507746 | PubTator, text mining | PubMed |
| SUZ domain-containing proteins have multiple effects on nonsense-mediated decay target transcripts. | J Biol Chem | 2023 | 37507022 | PubTator, text mining | PubMed |
| mTOR inhibition reprograms cellular proteostasis by regulating eIF3D-mediated selective mRNA translation and promotes cell phenotype switching. | Cell Rep | 2023 | 37494188 | PubTator, text mining | PubMed |
| Stage-specific coexpression network analysis of Myc in cohorts of renal cancer. | Sci Rep | 2023 | 37481674 | PubTator, text mining | PubMed |
| Nicotinamide mononucleotide (NMN) alleviates the poly(I:C)-induced inflammatory response in human primary cell cultures. | Sci Rep | 2023 | 37474783 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1973/papers?page=8